Lodicard (Amlodipine + Atenolol)

Therapeutic Group : Cardiovascular Presentation: Lodicard Tablet : Each tablet contains Amlodipine besilate BP equivalent to Amlodipine 5 mg and Atenolol BP 50 mg. Indications: Lodicard is indicated for the following conditions: 1) For the treatment of hypertension 2) For chronic stable angina 3) In post MI patients 4) In patients with refractory angina pectoris […]

Locaine (Lidocaine HCI)

Therapeutic Group : Anesthetic Presentation: Locaine Injection: Each ml contains Lidocaine Hydrochloride USP 20 mg. Indications: – To anaesthetize the area of the body where surgery is to be performed.– To provide pain relief in labour and after surgery. Dosage & Administration: The dosage is adjusted according to the response of the patient and site […]

Livcare (Obeticholic acid )

Therapeutic Group : Farnesoid X receptor agonists Presentation: Livcare-5 Tablet: Each film coated tablet contains Obeticholic Acid INN 5 mg.Livcare-10 Tablet: Each film coated tablet contains Obeticholic Acid INN 10 mg. Pharmacology: Obeticholic Acid is a Farnesoid X Receptor (FXR) agonist, a nuclear receptor expressed in the liver and intestine. FXR is a key regulator […]

Linaglip-M (Linagliptin + Metformin Hydrochloride)

Therapeutic Group : Antidiabetic Oral Presentation: Linaglip-M 2.5/500 Tablet: Each film coated tablet contains Linagliptin INN 2.5 mg & Metformin Hydrochloride BP 500 mg.Linaglip-M 2.5/850 Tablet: Each film coated tablet contains Linagliptin INN 2.5 mg & Metformin Hydrochloride BP 850 mg.Linaglip-M 5/1000 ER Tablet: Each film coated tablet contains Linagliptin INN 5 mg & Metformin […]

Linaglip (Linagliptin)

Therapeutic Group : Antidiabetic Presentation: Linaglip Tablet: Each film coated tablet contains Linagliptin INN 5 mg. Indications: Linaglip is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Linaglip may be used as monotherapy or in combination with other common antidiabetic medications including Metformin, Sulfonylurea, […]

Liftear (Lifitegrast INN)

Therapeutic Group : Immunomodulator & LFA-1 Antagonist Presentation: Liftear Ophthalmic Solution: Each ml contains Lifitegrast INN 50 mgPreservative: Sodium Perborate BP 0.01% Pharmacology: Lifitegrast is a novel lymphocyte function associated antigen 1 (LFA-1) antagonist. Itacts by inhibiting LFA-1 interaction with the intercellular adhesion molecule (ICAM)-1on the T-cell surface, inhibiting T-cell adhesion, migration, activation and subsequentcytokine […]

Laczym Chewable Tablet (Lactase)

Therapeutic Group : Enzyme Presentation: Laczym chewable tablet: Each chewable tablet contains Lactase USP 9000 IU. Indications: Laczym is indicated for preventing symptoms of lactose intolerance such as bloating, flatulence, diarrhea etc. Dosage & Administration: 1 tablet with dairy food. If needed dose can be adjusted up to 2 tablets at a time. Contrainidications: This […]

Lacicard (Lacidipine)

Therapeutic Group : Cardiovascular Presentation: Lacicard-2 Tablet: Each film coated tablet contains Lacidipine BP 2 mg.Lacicard-4 Tablet: Each film coated tablet contains Lacidipine BP 4 mg. Indications: Treatment of hypertension, either alone or in combination with other antihypertensive agents such as beta-blockers and diuretics. Dosage & Administration: Initially 2 mg as a single daily dose, […]

Ketozol (Ketoconazole)

Therapeutic Group : Antidandruff Presentation: Ketozol Shampoo: Each ml shampoo contains Ketoconazole USP 20 mg. Indications: Ketozol shampo in indicated in the treatment of•Dandruff (Pityriasis capitis)•Pityriasis versicolor (localized)•Inflammatory skin condition with greasy, red and scaly areas (Seborrhoeic dermatitis) Dosage & Administration: Dandruff (Pityriasis capitis) and Seborrhoeic dermatitis – Twice weekly for 2 – 4 weeks. […]

Joinflex-40 (Native Type II Collagen)

Therapeutic Group : Herbal Presentation: Joinflex-40 Capsule: Each capsule contains Native Type 2 Collagen 40 mg. Pharmacology: Native Type II Collagen molecules contain active binding sites called epitopes which trigger the process of oral tolerization. Through oral tolerization process, active epitopes of Native Type II Collagen interact with Peyer’s patches (lymphoid tissue) of small intestine […]